2
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Terminated
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Non-small Cell Lung Cancer Metastatic
1
Interventions
Specimen Handling
280
Magnetic Resonance Spectroscopy
233
pembrolizumab
220
Carboplatin
180
Cisplatin
146
Biopsy
146
Cyclophosphamide
138
Paclitaxel
128
Nivolumab
118
Bevacizumab
106
Gemcitabine
105
Radiotherapy
90
Dexamethasone
83
Pemetrexed
79
fludarabine
74
Docetaxel
74
atezolizumab
73
Fluorouracil
73
Doxorubicin
73
Radiation
72
Leucovorin
68
Rituximab
66
Oxaliplatin
64
venetoclax
60
Prednisone
60
durvalumab
58
Cetuximab
56
Vincristine
55
Etoposide
54
Lenalidomide
53
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
tusamitamab ravtansine
×
30 days
×
Clear all
NCT04154956
2026-05-18
CARMEN-LC03
Sanofi
Phase 3
Terminated
389 enrolled
16 charts